Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › LA › ABBEVILLE › ABBEVILLE GENERAL HOSPITAL

ABBEVILLE GENERAL HOSPITAL

NPI: 1255300414 · ABBEVILLE, LA 70510 · Rural Acute Care Hospital · NPI assigned 03/17/2006

$18.92M
Total Medicaid Paid
386,546
Total Claims
338,511
Beneficiaries
171
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHAIR, KELLY (DIRECTOR OF RURAL HEALTH CLINICS)
NPI Enumeration Date03/17/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 53,466 $2.00M
2019 61,223 $1.92M
2020 40,452 $1.47M
2021 56,333 $2.96M
2022 65,736 $3.73M
2023 64,178 $4.22M
2024 45,158 $2.62M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 29,622 26,994 $4.79M
99284 Emergency department visit for the evaluation and management, high severity 14,332 13,035 $4.18M
99282 Emergency department visit for the evaluation and management, low to moderate severity 12,877 11,725 $1.47M
41899 Unlisted procedure, dentoalveolar structures 2,237 1,980 $1.36M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 3,446 3,069 $1.12M
62323 1,623 1,478 $386K
80050 General health panel 8,158 7,381 $328K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 6,019 5,279 $314K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 5,615 4,889 $282K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 6,547 6,057 $270K
95811 153 146 $232K
80053 Comprehensive metabolic panel 30,110 26,550 $232K
95810 Polysomnography; sleep staging with 4 or more additional parameters 173 162 $217K
74176 Computed tomography, abdomen and pelvis; without contrast material 240 222 $212K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2,588 2,371 $204K
71045 Radiologic examination, chest; single view 2,518 2,300 $187K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 30,686 26,724 $176K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1,873 1,687 $174K
71046 Radiologic examination, chest; 2 views 2,598 2,298 $167K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 5,410 4,924 $163K
70450 Computed tomography, head or brain; without contrast material 411 375 $161K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 4,716 4,297 $151K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 4,689 4,264 $150K
80061 Lipid panel 11,932 10,946 $139K
36415 Collection of venous blood by venipuncture 56,850 48,473 $134K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 3,135 2,885 $101K
96361 Intravenous infusion, hydration; each additional hour 283 55 $94K
81025 13,015 11,781 $94K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 4,055 3,537 $94K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 6,452 5,796 $88K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 396 360 $88K
J7030 Infusion, normal saline solution , 1000 cc 2,417 1,599 $84K
76830 Ultrasound, transvaginal 487 445 $77K
83036 Hemoglobin; glycosylated (A1C) 8,434 7,696 $69K
87400 4,964 4,449 $59K
G0378 Hospital observation service, per hour 567 336 $55K
J1885 Injection, ketorolac tromethamine, per 15 mg 5,107 4,576 $54K
81001 20,621 18,211 $48K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 198 132 $47K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 587 449 $45K
95806 151 134 $37K
77067 Screening mammography, bilateral, including computer-aided detection 223 207 $33K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 193 182 $32K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 26 24 $30K
87086 Culture, bacterial; quantitative colony count, urine 4,437 3,874 $29K
83880 1,137 1,016 $24K
84484 3,250 2,729 $23K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 68 58 $21K
83970 765 716 $21K
0240U 153 147 $20K
73564 93 92 $19K
80081 242 217 $15K
86480 289 278 $15K
83690 2,647 2,342 $14K
82550 3,012 2,463 $13K
82553 1,857 1,520 $13K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 447 374 $12K
J7120 Ringers lactate infusion, up to 1000 cc 1,630 1,381 $11K
74019 170 150 $11K
J0696 Injection, ceftriaxone sodium, per 250 mg 497 433 $11K
82150 2,179 1,933 $11K
G0379 Direct admission of patient for hospital observation care 268 179 $10K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 443 404 $10K
84439 1,150 1,044 $9K
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 685 603 $9K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 359 232 $9K
J2405 Injection, ondansetron hydrochloride, per 1 mg 3,251 2,853 $8K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 91 82 $8K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 97 91 $7K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,595 1,423 $7K
81002 2,368 1,401 $6K
85610 2,417 2,139 $6K
84443 Thyroid stimulating hormone (TSH) 609 540 $6K
86850 1,344 1,230 $6K
94664 352 247 $5K
81003 3,737 2,998 $5K
76705 Ultrasound, abdominal, real time with image documentation; limited 17 17 $5K
J0561 Injection, penicillin g benzathine, 100,000 units 37 31 $4K
85730 1,042 896 $4K
99281 Emergency department visit for the evaluation and management, self-limited or minor 50 50 $4K
83020 295 273 $4K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 476 412 $3K
86803 314 283 $3K
87420 250 224 $3K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 180 79 $3K
72100 38 36 $3K
99223 Prolong inpt eval add15 m 56 27 $3K
87340 311 280 $2K
82570 690 644 $2K
96375 Therapeutic injection; each additional sequential IV push 28 12 $2K
86038 243 217 $2K
86592 554 496 $2K
83605 237 210 $2K
J2704 Injection, propofol, 10 mg 3,869 3,043 $2K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 15 12 $2K
84156 696 650 $2K
87634 28 25 $2K
84702 123 109 $2K
82728 146 117 $1K
85018 1,027 775 $1K
73610 13 12 $1K
86140 316 286 $1K
94760 425 262 $1K
J2795 Injection, ropivacaine hydrochloride, 1 mg 47 43 $1K
87186 147 130 $995.45
87040 124 72 $987.39
87077 147 131 $981.87
85027 1,763 1,630 $967.10
83550 147 117 $958.44
83735 194 156 $956.99
86431 226 204 $952.56
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 118 88 $873.02
80048 Basic metabolic panel (calcium, ionized) 139 100 $870.95
86200 83 67 $786.86
83540 159 130 $769.10
87081 108 104 $649.74
82950 135 131 $589.00
86901 228 201 $575.03
86900 229 201 $572.04
82677 26 26 $556.14
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 14 13 $519.96
J3490 Unclassified drugs 1,015 686 $486.04
J0131 Injection, acetaminophen, not otherwise specified,10 mg 74 70 $477.77
J0571 Buprenorphine, oral, 1 mg 207 28 $462.77
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 75 51 $459.84
82105 26 26 $385.71
80076 57 42 $381.38
J3010 Injection, fentanyl citrate, 0.1 mg 815 750 $369.22
86336 26 26 $358.57
82248 77 69 $326.37
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 1,622 1,211 $303.26
J1335 Injection, ertapenem sodium, 500 mg 70 62 $300.32
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,166 1,935 $284.18
J0690 Injection, cefazolin sodium, 500 mg 192 133 $275.90
86225 26 24 $274.80
82607 26 17 $269.86
J2360 Injection, orphenadrine citrate, up to 60 mg 13 12 $260.80
84481 26 25 $241.74
84100 77 46 $225.35
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 506 481 $222.81
84153 12 12 $220.68
82043 29 29 $212.90
83721 91 41 $189.47
J2919 Injection, methylprednisolone sodium succinate, 5 mg 15 12 $171.17
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 23 18 $164.22
J2270 Injection, morphine sulfate, up to 10 mg 175 143 $145.82
S0028 Injection, famotidine, 20 mg 13 13 $94.78
82962 26 14 $82.94
84550 24 23 $72.32
J2250 Injection, midazolam hydrochloride, per 1 mg 551 494 $54.29
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 19 13 $44.83
A9150 Non-prescription drugs 28 26 $30.16
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 110 99 $28.46
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 147 141 $0.00
G0177 Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) 268 30 $0.00
T1015 Clinic visit/encounter, all-inclusive 95 30 $0.00
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 60 56 $0.00
Q0243 Injection, casirivimab and imdevimab, 2400 mg 13 13 $0.00
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 144 126 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 14 12 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 147 98 $0.00
92551 51 40 $0.00
00000 224 210 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 978 890 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 992 909 $0.00
G0410 Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes 665 56 $0.00
J7060 5% dextrose/water (500 ml = 1 unit) 134 101 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 287 257 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 27 25 $0.00
99308 Subsequent nursing facility care, per day, straightforward 190 183 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 15 12 $0.00